Get the Stockscreener App
108.02
0.35%
-0.39
Zimmer Biomet Holdings Inc stock is traded at $108.02, with a volume of 500.01K.
It is down -0.35% in the last 24 hours and up +3.20% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$108.41
Open:
$107.79
24h Volume:
500.01K
Relative Volume:
0.35
Market Cap:
$21.45B
Revenue:
$7.52B
Net Income/Loss:
$997.10M
P/E Ratio:
44.82
EPS:
2.41
Net Cash Flow:
$1.11B
1W Performance:
+3.99%
1M Performance:
+3.20%
6M Performance:
-11.20%
1Y Performance:
-0.66%
1-Day Range:
$107.47
$108.37
1-Week Range:
$106.59
$109.96
52-Week Range:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
New York State Common Retirement Fund Has $19.66 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Royal Bank of Canada Issues Positive Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
NeuroOne agree $3m partnership with Zimmer Biomet - Medical Device Network
Zimmer licenses NeuroOne brain ablation system - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by US Bancorp DE - MarketBeat
FY2024 EPS Estimates for Zimmer Biomet Reduced by Analyst - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Expands with NeuroOne Alliance and Z1 Hip System Launch - Yahoo Finance
Van ECK Associates Corp Has $391.24 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Results: Zimmer Biomet Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Zimmer Biomet Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Zimmer Biomet net sales surge 4% to USD 1.824B in Q3 2024 - Medical Buyer
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Position Reduced by New York State Teachers Retirement System - MarketBeat
ZBH Stock Up Despite Q3 Earnings Miss, 2024 View Narrowed - MSN
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Truist Financial Issues Positive Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
Nisa Investment Advisors LLC Sells 6,237 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE:ZBH) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2024 Earnings Call Transcript - Insider Monkey
Bone Growth Products Market Insights Report, 2024-2029: Competition Intensifies as Key Players Drive Growth Through Innovation, Strategic Partnerships, and Advanced Therapies - GlobeNewswire Inc.
Do Zimmer Biomet Holdings' (NYSE:ZBH) Earnings Warrant Your Attention? - Yahoo Finance
Zimmer Biomet Holdings Inc (ZBH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ERP Challenges - GuruFocus.com
abrdn plc Sells 85,169 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer: Q3 Earnings Snapshot - The Advocate
Zimmer Biomet Holdings Inc (ZBH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Zimmer Biomet Reports Solid Q3 2024 Performance - TipRanks
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Holdings, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2017; Announces Goodwill Impairment for the Fourth Quarter Ended December 31, 2017; Provides Earnings Guida - Marketscreener.com
Zimmer Biomet Holdings reports third-quarter earnings increase - Fort Wayne Journal Gazette
Earnings call: Zimmer Biomet reports growth amidst ERP challenges - Investing.com
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts - Benzinga
Zimmer Biomet's Profit Dips Due To ERP Software Woes - Finimize
Zimmer (ZBH) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Implant maker Zimmer Biomet lowers full-year profit forecast - Reuters
Stryker, Zimmer outline different M&A strategies - Yahoo Finance
Zimmer Biomet narrows full-year outlook, shares dip By Investing.com - Investing.com South Africa
Zimmer Biomet Holdings Inc (ZBH) Q3 2024 Earnings: EPS of $1.23 Beats Estimates, Revenue Hits $1.824 Billion - GuruFocus.com
Zimmer Biomet Announces Third Quarter 2024 Financial Results - XM
Zimmer Biomet earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Zimmer Biomet Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Raymond James & Associates Reduces Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Q3 2024 Earnings Preview - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth plans - Investing.com Nigeria
Zimmer Biomet to launch Z1 Femoral Hip System By Investing.com - Investing.com Canada
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth plans By Investing.com - Investing.com South Africa
Zimmer Biomet Seeks to Place More Rosa Robots in Outpatient Settings - Morningstar
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting - Quantisnow
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical D - GuruFocus.com
Zimmer Biomet to launch Z1 Femoral Hip System - Investing.com India
Forsta AP Fonden Has $10.51 Million Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet falls on potential revenue hit from software issue - MSN
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.53%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):